board of directors careers technology pipeline overview probuphine ropinirole implant t3 implant news overview press releases events presentations publications posters media resources investors investor relations overview news events press releases ir calendar email alerts company info company information profile presentations management team contacts faq financial info financials financial results stock data quote charts historical data sec filings all sec filings annual reports quarterly reports section 16 filings governance board of directors board committees governance documents contact search innovations in medicine proneura titan s innovative drug delivery platform is advancing the treatment of select chronic diseases by delivering low dose non fluctuating medication levels for up to one year following a single procedure learn more about innovations in medicine product pipeline probuphine for the treatment of opioid addiction market completed market completed market completed market completed market in progress preclinical phase 1 phase 2 phase 3 market more about probuphine product pipeline ropinirole implant for the treatment of parkinson s disease preclinical in progress preclinical not started preclinical not started preclinical not started preclinical not started preclinical phase 1 phase 2 phase 3 market more about ropinirole implant product pipeline t3 implant for the treatment of hypothyroidism preclinical in progress preclinical not started preclinical not started preclinical not started preclinical not started preclinical phase 1 phase 2 phase 3 market more about t3 implant about titan pharmaceuticals titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long term continuous drug delivery platform proneura . more about titan pharmaceuticals information for investors titan pharmaceuticals inc. nasdaq ttnp volume day low high 52 week low high average volume market cap most recent news & press releases august 9 2016 titan pharmaceuticals reports second quarter 2016 financial results view all news & releases view investor relations download our investor presentation view sec filings 2016 titan pharmaceuticals inc. all rights reserved . privacy policy disclaimer sitemap